天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Fluoxetine HCl

別名: Lilly 110140 HCl, LY-110140 HCl 中文名稱：鹽酸氟西汀

Fluoxetine HCl是一種抗抑郁劑，選擇性抑制5-羥色胺再攝取。

Fluoxetine HCl Chemical Structure

Fluoxetine HCl Chemical Structure

CAS: 56296-78-7

規(guī)格 價格 庫存 購買數(shù)量
10mM (1mL in DMSO) 997 現(xiàn)貨
10mg 794.43 現(xiàn)貨
25mg 1217.77 現(xiàn)貨
100mg 2446.52 現(xiàn)貨
1g 8763.3 現(xiàn)貨
更大包裝 有超大折扣

400-668-6834

info@selleck.cn
免費分裝
免費預(yù)溶

Fluoxetine HCl相關(guān)產(chǎn)品

相關(guān)信號通路圖

5-HT Receptor Signaling Pathways

5-HT Receptor信號通路圖

細胞實驗數(shù)據(jù)示例

細胞系 實驗類型 給藥濃度 孵育時間 活性描述 文獻信息
HEK293 Function assay 30 mins Inhibition of human SERT expressed in HEK293 cells assessed as inhibition of serotonin reuptake after 30 mins by fluorescence assay, IC50=0.15μM 22938049
HEK293 Function assay 30 mins Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake after 30 mins by fluorescence assay, IC50=4.41μM 22938049
HEK293 Function assay 30 mins Inhibition of human DAT expressed in HEK293 cells assessed as inhibition of dopamine reuptake after 30 mins by fluorescence assay, IC50=18.4μM 22938049
BESM Antitrypanosomal assay 88 hrs Antitrypanosomal activity against Trypanosoma cruzi amastigotes infected in BESM cells measured after 88 hrs postinfection by HTS assay, EC50=7μM 20547819
BESM Cytotoxicity assay 88 hrs Cytotoxicity against BESM cells after 88 hrs by HTS assay, EC50=16μM 20547819
HEK293 Function assay 60 mins Displacement of [3H]Paroxetine from human recombinant SERT expressed in HEK293 cells after 60 mins, Ki=0.0014μM 23403082
HEK293 Function assay 60 mins Displacement of [3H]Paroxetine from human recombinant SERT expressed in HEK293 cells after 60 mins, IC50=0.0086μM 23403082
HEK293 Function assay 10 mins Inhibition of [3H]5-HT uptake at human SERT expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay, Ki=0.098μM 23602445
HEK293 Function assay 10 mins Inhibition of [3H]5-HT uptake at human SERT expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay, IC50=0.28184μM 23602445
HEK293 Function assay 10 mins Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay, Ki=1.394μM 23602445
HEK293 Function assay 10 mins Inhibition of [3H]dopamine uptake at human DAT expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay, Ki=3.764μM 23602445
HEK293 Function assay 10 mins Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay, IC50=6.30957μM 23602445
HEK293 Function assay 10 mins Inhibition of [3H]dopamine uptake at human DAT expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay, IC50=9.12011μM 23602445
HEK293 Function assay 15 mins Inhibition of serotonin reuptake at human SERT expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay, IC50=0.15μM 24974340
HEK293 Function assay 15 mins Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay, IC50=4.41μM 24974340
HEK293 Function assay 15 mins Inhibition of DA reuptake at human DAT expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay, IC50=18.4μM 24974340
HEK293 Function assay 15 mins Inhibition of human SERT expressed in HEK293 cells at incubated for 15 mins by neurotransmitter reuptake assay, IC50=0.15μM 25221656
HEK293 Function assay 15 mins Inhibition of human NET expressed in HEK293 cells at incubated for 15 mins by neurotransmitter reuptake assay, IC50=4.41μM 25221656
HEK293 Function assay 15 mins Inhibition of human DAT expressed in HEK293 cells at incubated for 15 mins by neurotransmitter reuptake assay, IC50=18.4μM 25221656
RD Antiviral assay 5 mins Antiviral activity against Enterovirus D68 US/KY/14-18953 infected in human RD cells assessed as inhibition of virus-induced cytopathic effect incubated for 5 mins under shaking condition and measured after 3 days by neutral red dye-based photometric meth, EC50=1μM 30912944
RD Cytotoxicity assay 3 days Cytotoxicity against human RD cells after 3 days by neutral red dye-based photometric method, CC50=11.9μM 30912944
mammalian cells Function assay Inhibition of human Potassium channel HERG expressed in mammalian cells, IC50=1.51356μM 12873512
JAR Function assay Inhibition concentration against [3H]5-HT uptake by human serotonin transporter in JAR cells, IC50=0.0324μM 15239661
K562 Cytotoxicity assay Cytotoxicity to reduce chronic myeloid leukemia K 562 cells, CC50=25μM 15267229
U937 Cytotoxicity assay Cytotoxicity to reduce human histolytic lymphoma U937 cells, CC50=33.3μM 15267229
HEK293 Function assay Inhibition of [3H]5-HT uptake at 5HT transporter expressed in HEK293 cells, IC50=0.016μM 16750359
HEK293 Function assay Inhibition of DA transporter expressed in HEK293 cells, IC50=4.4μM 16750359
HEK293 Function assay Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells, IC50=5.2μM 16750359
HEK293 Function assay Inhibition of [3H]5-HT reuptake at 5HT transporter in HEK293 cells, IC50=0.016μM 16750363
HEK293 Function assay Inhibition of [3H]DA reuptake at DA transporter in HEK293 cells, IC50=4.4μM 16750363
HEK293 Function assay Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells, IC50=5.2μM 16750363
Jar Function assay Inhibition of [3H]5-HT uptake at human 5-HT transporter expressed in Jar cells, IC50=0.0394μM 16854086
SK-N-MC Function assay Displacement of N-[3H]alpha-methylhistamine from human histamine H3 receptor expressed in SK-N-MC cells, Ki=7.3μM 17307358
CHO Function assay Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique, IC50=1.51356μM 18448342
HEK293 Function assay Inhibition of serotonin uptake at human SERT in human HEK293 cells, IC50=0.047μM 18550369
HEK293 Function assay Inhibition of norepinephrine uptake at human NET in human HEK293 cells, IC50=2μM 18550369
HEK293 Function assay Inhibition of dopamine uptake at human DAT in human HEK293 cells, IC50=6μM 18550369
JAR Function assay Inhibition of 5HT uptake at human SERT expressed in human JAR cells, IC50=0.0094μM 18557608
HEK Function assay Inhibition of serotonin uptake at human SERT expressed in HEK cells, IC50=0.047μM 18667309
HEK Function assay Inhibition of norepinephrine uptake at human NET expressed in HEK cells, IC50=2μM 18667309
HEK Function assay Inhibition of dopamine uptake at human DAT expressed in HEK cells, IC50=6μM 18667309
JAR Function assay Inhibition of serotonin uptake at human SERT expressed in JAR cells, IC50=0.01μM 18771916
MDCK Function assay Inhibition of norepinephrine uptake at human NET expressed in MDCK cells, IC50=0.563μM 18771916
Jar Function assay Inhibition of 5-HT transporter-mediated [3H]5HT uptake in human Jar cells, IC50=0.0394μM 18834188
JAR Function assay Inhibition of serotonin uptake at human SERT expressed in JAR cells, IC50=0.0094μM 18951020
HEK293 Function assay Displacement of [125I]RTI55 from human recombinant SERT expressed in HEK293 cells, Ki=0.0011μM 19014888
HEK293 Function assay Inhibition of [3H]5HT from human recombinant SERT expressed in HEK293 cells, IC50=0.007μM 19014888
HEK293 Function assay Inhibition of [3H]NE from human recombinant NET expressed in HEK293 cells, IC50=1.02μM 19014888
HEK293 Function assay Displacement of [125I]RTI55 from human recombinant NET expressed in HEK293 cells, Ki=1.56μM 19014888
HEK293 Function assay Displacement of [125I]RTI55 from human recombinant DAT expressed in HEK293 cells, Ki=6.67μM 19014888
HEK293 Function assay Inhibition of [3H]DA from human recombinant DAT expressed in HEK293 cells, IC50=19.5μM 19014888
HEK293 Function assay Displacement of [125I]RTI-55 from human recombinant SERT expressed in HEK293 cells by scintillation counting, Ki=0.0011μM 19256502
HEK293 Function assay Displacement of [3H]serotonin from human recombinant SERT expressed in HEK293 cells by scintillation counting, IC50=0.0073μM 19256502
HEK293 Function assay Displacement of [3H]norepinephrine from human recombinant NET expressed in HEK293 cells by scintillation counting, IC50=1.02μM 19256502
HEK293 Function assay Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting, Ki=1.56μM 19256502
HEK293 Function assay Displacement of [125I]RTI-55 from human recombinant DAT expressed in HEK293 cells by scintillation counting, Ki=6.67μM 19256502
HEK293 Function assay Displacement of [3H]dopamine from human recombinant DAT expressed in HEK293 cells by scintillation counting, IC50=19.5μM 19256502
JAR Function assay Inhibition of serotonin uptake at human SERT expressed in human JAR cells, IC50=0.01μM 19329313
MDCK-Net6 Function assay Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells, IC50=0.563μM 19329313
JAR Function assay Inhibition of serotonin uptake at human SERT expressed in JAR cells, IC50=0.0094μM 19632110
JAR Function assay Inhibition of human SERT expressed in JAR cells, IC50=0.0094μM 19713106
JAR Function assay Inhibition of [3H]hydroxytryptamine creatinine sulfate uptake at human SERT expressed in human JAR cells, IC50=0.0094μM 19722525
HEK293 Function assay Displacement of [I125]RTI-55 from human SERT transfected in human HEK293 cells, IC50=0.0025μM 20034793
JAR Function assay Inhibition of serotonin uptake at human SERT expressed in human JAR cells, IC50=0.0094μM 20131864
JAR Function assay Inhibition of human SERT expressed in human JAR cells, IC50=0.0094μM 20378347
JAR Function assay Inhibition of SERT-mediated serotonin uptake in human JAR cells, IC50=0.0094μM 20462211
HEK293 Function assay Displacement of [3H] astemizole from human recombinant ERG channel expressed in HEK293 cells, IC50=3.1μM 20637635
HEK293 Function assay Inhibition of serotonin reuptake at human SERT expressed in HEK293 cells, IC50=0.0031μM 20724153
HEK293 Function assay Inhibition of [3H]serotonin reuptake at human SERT expressed in HEK293 cells by scintillation counting, IC50=0.0052μM 21093273
LLC-PK1 Function assay Inhibition of [3H]serotonin reuptake at human recombinant SERT expressed in LLC-PK1 cells by liquid scintillation counting, IC50=0.005012μM 21310612
HEK293 Function assay Inhibition of serotonin reuptake at SERT expressed in HEK293 cells, IC50=0.005012μM 21739935
JAR Function assay Inhibition of human SERT expressed in JAR cells assessed as serotonin uptake, IC50=0.0094μM 21916421
HEK293 Function assay Inhibition of human SERT-mediated serotonin reuptake in HEK293 cells, EC50=0.0027μM 21927645
CHO Function assay Inhibition of rat voltage-gated K channel 3.1 expressed in CHO cells by patch clamp assay, IC50=13.1μM 23121096
HEK293 Function assay Displacement of [3H]imipramin from human recombinant SERT over-expressed in HEK293 cells, IC50=0.0072μM 24012181
HEK293 Function assay Inhibition of of human TREK1 expressed in HEK293 cells assessed as reduction in channel currents, IC50=14μM 26588045
tsA201 Function assay Inhibition of of human TREK1 expressed in tsA201 cells assessed as reduction in channel currents, IC50=19μM 26588045
OHS-50 qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells 29435139
MG 63 (6-TG R) qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells 29435139
Huh7 Antiviral assay Antiviral activity against DENV2 infected in human Huh7 cells by qRT-PCR analysis, IC50=0.38μM 31128447
點擊查看更多細胞系數(shù)據(jù)

生物活性

產(chǎn)品描述 Fluoxetine HCl是一種抗抑郁劑，選擇性抑制5-羥色胺再攝取。
靶點
5-HT [1]
體外研究(In Vitro)
體外研究活性

Fluoxetine阻斷細胞增殖的下調(diào)，導致海馬細胞的不可避免的沖擊（IS）。[1]

Fluoxetine增加成年大鼠的海馬的齒狀回的新生細胞的數(shù)量。Fluoxetine也增加了前度皮質(zhì)的增殖細胞的數(shù)目。[2]

Fluoxetine加速未成熟神經(jīng)元的成熟。Fluoxetine增強海馬齒狀回的神經(jīng)依賴的長時程增強（LTP）。[3]

Fluoxetine而不是Citalopram, Fluvoxamine, Paroxetine和Sertraline，增加前額葉皮層中去甲腎上腺素和多巴胺的細胞外水平。在急性全身給藥后，Doxazosin產(chǎn)生強勁而持續(xù)增加的去甲腎上腺素和多巴胺的胞外濃度。[4]
體內(nèi)研究(In Vivo)
體內(nèi)研究活性

在動物成年雄性SD大鼠中，F(xiàn)luoxetine扭轉(zhuǎn)不可避免的沖擊導致的逃避潛伏期。[1]

在動物成年雄性SD大鼠中，F(xiàn)luoxetine和Olanzapine聯(lián)用產(chǎn)生穩(wěn)健，持續(xù)的細胞外多巴胺水平（[DA]（前））和去甲腎上腺素（[東北]（前））的增加，超過基準達361％和272％，這是顯著大于兩種藥物單獨使用。[5]
NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT05634707 Recruiting
Primary Brain Tumor|Brain Tumor Recurrent
Duke University
 August 5 2023 Early Phase 1
NCT04676139 Unknown status
Nocturnal Enuresis
Mansoura University
 July 1 2020 Phase 3
NCT01615055 Withdrawn
Cognitive Dysfunction
University of California Los Angeles|City of Hope Medical Center
 June 2018 Early Phase 1
NCT03390933 Completed
Depression|Hemodialysis-Induced Symptom
MetroHealth Medical Center
 March 1 2018 Phase 4

化學信息&溶解度

分子量 345.79 分子式

C17H18F3NO.HCl
CAS號 56296-78-7 SDF Download Fluoxetine HCl SDF
Smiles CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F.Cl
儲存條件(自收到貨起)

體外溶解度
批次：

DMSO : 69 mg/mL ( (199.54 mM) ；DMSO吸濕會降低化合物溶解度，請使用新開封DMSO)

Ethanol : 69 mg/mL (199.54 mM)

Water : 4 mg/mL (11.56 mM)

摩爾濃度計算器

體內(nèi)溶解度
批次：

現(xiàn)配現(xiàn)用，請按從左到右的順序依次添加，澄清后再加入下一溶劑

 動物體內(nèi)配方計算器

實驗計算

摩爾濃度計算器

質(zhì)量 濃度 體積 分子量

動物體內(nèi)配方計算器（澄清溶液）

第一步：請輸入基本實驗信息（考慮到實驗過程中的損耗，建議多配一只動物的藥量）

mg/kg g μL 只

第二步：請輸入動物體內(nèi)配方組成（配方適用于不溶于水的藥物；不同批次藥物配方比例不同，請聯(lián)系Selleck為您提供正確的澄清溶液配方）

% DMSO % % Tween 80 % ddH2O
%DMSO %

計算結(jié)果：

工作液濃度： mg/ml；

DMSO母液配制方法： mg 藥物溶于μL DMSO溶液（母液濃度mg/mL，注：如該濃度超過該批次藥物DMSO溶解度，請先聯(lián)系Selleck）；

體內(nèi)配方配制方法：取μL DMSO母液，加入μL PEG300，混勻澄清后加入μL Tween 80，混勻澄清后加入μL ddH2O，混勻澄清。

體內(nèi)配方配制方法：取μL DMSO母液，加入μL Corn oil，混勻澄清。

注意：1. 首先保證母液是澄清的；
2.一定要按照順序依次將溶劑加入，進行下一步操作之前必須保證上一步操作得到的是澄清的溶液，可采用渦旋、超聲或水浴加熱等物理方法助溶。

技術(shù)支持

在訂購、運輸、儲存和使用我們的產(chǎn)品的任何階段，您遇到的任何問題，均可以通過撥打我們的熱線電話400-668-6834，或者技術(shù)支持郵箱tech@selleck.cn，直接聯(lián)系到我們。我們會在24小時內(nèi)盡快聯(lián)系您。

操作手冊

如果有其他問題，請給我們留言。

* 必填項

請輸入您的姓名
請輸入您的郵箱地址 請輸入一個有效的郵箱地址
請寫點東西給我們
Tags: buy Fluoxetine HCl | Fluoxetine HCl supplier | purchase Fluoxetine HCl | Fluoxetine HCl cost | Fluoxetine HCl manufacturer | order Fluoxetine HCl | Fluoxetine HCl distributor
在線咨詢
聯(lián)系我們